Article thumbnail

CLSM as Quantitative Method to Determine the Size of Drug Crystals in a Solid Dispersion

By Hans de Waard, Martin J. T. Hessels, Maarten Boon, Klaas A. Sjollema, Wouter L. J. Hinrichs, Anko C. Eissens and Henderik W. Frijlink
Topics: Research Paper
Publisher: Springer US
OAI identifier: oai:pubmedcentral.nih.gov:3170464
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. A comparative study of topdown and bottom-up approaches for the preparation of micro/ nanosuspensions.
  2. A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze drying.
  3. (1996). An analysis of the Fraunhofer Diffraction method for particle size distribution analysis and its application to aerosolized sprays.
  4. (2001). Characterization of the solid-state: spectroscopic techniques. Adv Drug Deliv Rev.
  5. Controlled crystallization of the lipophilic drug fenofibrate during freeze-drying: Elucidation of the mechanism by in-line Raman spectroscopy.
  6. (2007). Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev.
  7. (2005). Deconvolution microscopy. In:
  8. (1999). Determination of interfacial tension from crystallization and dissolution data: a comparison with other methods. Adv Colloid Interface Sci.
  9. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology.
  10. Energy/temperature diagram and compression behavior of the polymorphs of D-mannitol.
  11. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev.
  12. Fluorescence quenching of dipyridamole associated to peroxyl radical scavenging: a versatile probe to measure the chain breaking antioxidant activity of biomolecules.
  13. (2002). Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media. Pharm Res.
  14. In vitro-in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol.
  15. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards.
  16. (2004). Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm.
  17. (2007). Pharmaceutical applications of confocal laser scanning microscopy: The physical characterisation of pharmaceutical systems. Adv Drug Deliv Rev.
  18. (1998). Physical chemical properties of oral drug candidates in the discovery and exploratory development settings. Pharm Sci Technol Today.
  19. Physicochemical assessments of parenteral lipid emulsions: light obscuration versus laser diffraction.
  20. (2007). Raman chemical imaging for ingredient-specific particle size characterization of aqueous suspension nasal spray formulations: a progress report. Pharm Res.
  21. Size analysis of submicron particles by laser diffractometry-90% of the published measurements are false.
  22. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds.
  23. The production and characteristics of solid lipid nanoparticles (SLNs).
  24. The rate of solution of solid substances in their own solutions.